All-oral metronomic DEVEC schedule in elderly patients with peripheral T cell lymphoma.

Maria Christina CoxMarta BanchiSabrina PellicciaArianna Di NapoliLuigi MarcheselliCaterina PattiPaola Anticoli BorzaRoberta BattistiniFrancesca Di GregorioPaola OrlandiGuido Bocci

Published in: Cancer chemotherapy and pharmacology (2020)

All-oral DEVEC showed an encouraging activity and acceptable toxicity. This schedule deserves further studies in elderly PTCL also for assessing combinations with targeted drugs.

Keyphrases

middle aged
community dwelling
oxidative stress
cancer therapy
case control
chemotherapy induced